Grant focus
To develop long-acting formulations of key medicines and create a market for them

Grantees
University of Liverpool

Status
Current

Amount
US$ 32,004,459

Disease
HIV and Co-Infection, Malaria, Tuberculosis

Grant focus
Bringing secondary prevention of cervical cancer to scale in low- and middle-income countries

Grantees
Expertise France

Status
Current

Amount
US$ 24,322,600

Disease
HIV and Co-Infection

Grant focus
To transform oral HIV treatment into a long-acting injectable

Grantees
University of Washington

Status
Current

Amount
US$ 6,962,027

Disease
HIV and Co-Infection

Grant focus
To bring better pediatric medicines for drug-resistant TB

Grantees
Stellenbosch University (SU)

Status
Current

Amount
US$ 18,926,925

Disease
Tuberculosis

Grant focus
To pilot targeted next-generation sequencing, an innovation that provides fast, accurate diagnosis of drug-resistant TB

Grantees
Foundation for Innovative New Diagnostics (FIND)

Status
Current

Amount
US$ 14,500,000

Disease
Tuberculosis

Grant focus
To create affordable solutions for preventing cervical cancer

Grantees
Clinton Health Access Initiative (CHAI)

Status
Current

Amount
US$ 32,958,435

Disease
HIV and Co-Infection

Grant focus
To harness mobile technology to help patients adhere to their TB medications

Grantees
KNCV Tuberculosis Foundation

Status
Current

Amount
US$ 13,998,007

Disease
Tuberculosis

Grant focus
Catalysing access to an affordable advanced HIV disease package of care that can be scaled up by countries and funding partners

Grantees
Clinton Health Access Initiative (CHAI)

Status
Current

Amount
US$ 20,000,000*

Disease
HIV and Co-Infection